Tori Poplaski

Ms. Tori Poplaski

Baylor College of Medicine

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
Tori PoplaskiTori Poplaski
Tori Poplaski
CBCarolyn Bomidi
Carolyn Bomidi
AKAmal Kambal
Amal Kambal
HNHoa Nguyen-Phuc
Hoa Nguyen-Phuc
SRSara C. Di Rienzi
Sara C. Di Rienzi
SBSarah Elizabeth Blutt
Sarah Elizabeth Blutt
Cronkhite-Canada Syndrome (CCS) is a rare, noninherited polyposis syndrome affecting 1 in every million individuals. Despite over 50 years of CCS cases, the etiopathogenesis and optimal treatment for CCS remains unknown due to the rarity of the disease and lack of model systems. To better understand the etiology of CCS, we generated human intestinal organoids (HIOs) from intestinal stem cells isolated from 2 patients. We discovered that CCS HIOs are highly proliferative and have increased numbers of enteroendocrine cells producing serotonin (also known as 5-hydroxytryptamine or 5HT). These features were also confirmed in patient tissue biopsies. Recombinant 5HT increased proliferation of non-CCS donor HIOs and inhibition of 5HT production in the CCS HIOs resulted in decreased proliferation, suggesting a link between local epithelial 5HT production and control of epithelial stem cell proliferation. This link was confirmed in genetically engineered HIOs with an increased number of enteroendocrine cells. This work provides a new mechanism to explain the pathogenesis of CCS and illustrates the important contribution of HIO cultures to understanding disease etiology and in the identification of novel therapies. Our work demonstrates the principle of using organoids for personalized medicine and sheds light on how intestinal hormones can play a role in intestinal epithelial proliferation.

20 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
GAGrace O. Adeniyi-Ipadeola
Grace O. Adeniyi-Ipadeola
JHJulia D. Hankins
Julia D. Hankins
AKAmal Kambal
Amal Kambal
XZXi-Lei Zeng
Xi-Lei Zeng
KPKetki Patil
Ketki Patil
SRSasirekha Ramani
Sasirekha Ramani
Background & Aims Human intestinal enteroids (HIEs) are gaining recognition as physiologically relevant models of the intestinal epithelium. While HIEs from adults are used extensively in biomedical research, few studies have used HIEs from infants. Considering the dramatic developmental changes that occur during infancy, it is important to establish models that represent the infant intestinal anatomy and physiological responses. Methods We established jejunal HIEs from infant surgical samples and performed comparisons to jejunal HIEs from adults using RNA sequencing (RNA-Seq) and morphologic analyses. We validated differences in key pathways through functional studies and determined if these cultures recapitulate known features of the infant intestinal epithelium. Results RNA-Seq analysis showed significant differences in the transcriptome of infant and adult HIEs, including differences in genes and pathways associated with cell differentiation and proliferation, tissue development, lipid metabolism, innate immunity, and biological adhesion. Validating these results, we observed as higher expression of enterocytes, goblet cells and enteroendocrine cells in differentiated infant HIEs, and greater numbers of proliferative cells in undifferentiated cultures. Compared to adult HIEs, infant HIEs portray characteristics of an immature gastrointestinal epithelium including significantly shorter cell height, lower epithelial barrier integrity, and lower innate immune responses to infection with an oral poliovirus vaccine. Conclusions HIEs established from infant intestinal tissues reflect characteristics of the infant gut and are distinct from adult cultures. Our data support the use of infant HIEs as an ex-vivo model to advance studies of infant-specific diseases and drug discovery for this population. Created with Biorender.com

23 January 2020 in Insects
Verified
Journal Article
Open access
PDF file
ECElizabeth Cieniewicz
Elizabeth Cieniewicz
Tori PoplaskiTori Poplaski
Tori Poplaski
MBMelina Brunelli
Melina Brunelli
JDJason Dombroskie
Jason Dombroskie
Marc F. FuchsMarc F. Fuchs
Marc F. Fuchs
Spissistilus festinus (Say, 1830) (Hemiptera: Membracidae) is a frequent pest of leguminous crops in the Southern United States, and a vector of grapevine red blotch virus. There is currently no information on the genetic diversity of S. festinus. In this study, populations of S. festinus were collected in 2015–2017 from various crops and geographic locations in the United States, and fragments of the mitochondrial cytochrome C oxidase 1 (mt-COI) gene and the nuclear internal transcribed spacer 2 (ITS2) region were characterized by polymerase chain reaction and sequencing. Maximum-likelihood and Bayesian analyses of the mt-COI and ITS2 sequences yielded similar phylogenetic tree topologies, revealing two distinct genetic S. festinus lineages with all of the specimens from California comprising one phylogenetic clade, alongside a single GenBank entry from Arizona, and all specimens from the Southeastern United States comprising a statistically-supported distinct clade, regardless of host and year of collection. The mt-COI gene fragment showed up to 10.8% genetic distance between the two phylogenetic clades. These results suggest the existence of two genotypes within S. festinus in the United States. The only distinct morphological trait between the two genotypes was a less elevated pronotum in the representative specimens from California, compared to the representative specimens from the Southeastern United States. Since this phenotypic feature is inconspicuous, a diagnostic polymerase chain reaction targeting a variable region of the mt-COI fragment was developed to reliably distinguish between the specimens of the two genotypes of S. festinus and to facilitate their specific identification.

15 June 2022 in Cancer Research
Verified
Journal Article
Open access
NBNobel Bhasin
Nobel Bhasin
PDPrerna Dabral
Prerna Dabral
Tori PoplaskiTori Poplaski
Tori Poplaski
LLLisa Lai
Lisa Lai
HTHong-Yuan Tsai
Hong-Yuan Tsai
RCRu Chen
Ru Chen
Inflammatory bowel disease (IBD) increases the risk of developing colorectal cancer by 60%. The composition of gut flora and its interaction with mucosal cells plays a key role in the development of IBD and colorectal cancer. However, the actual cause-effect relationship between dysbiosis of the gut microbiome and human IBD and associated colorectal cancer has not been well established. In the current study, we sought to characterize colon mucosa adherent microbiota using metaproteomics to understand the colon micro-environment and the host-microbiome interactions. Three groups of colon biopsies were included in our analysis: healthy controls, Non-progressors (IBD patients without dysplasia or cancer) and Progressors (IBD patients who have dysplasia or cancer). The biopsy samples were analyzed by LC MS/MS and the bacterial proteins were identified using the Human Microbiome Project (HMP) human gut microbiome database. The inferences of bacterial taxonomy, bacterial enzymes and Gene ontology (GO) pathways were processed through Unipept. Examining bacterial composition between different sample groups showed no statistically significant difference at the levels of phyla and classes. However, a significant reduction of Holdemanella biformis was observed when comparing Progressors vs Non-progressors. Holdemanella biformis has recently been proposed to be endogenous anti-tumourigenic bacterial strains. Decrease of this bacterial species in Progressors suggested that it may be a protective bacteria preventing the progression of IBD associated colorectal cancer. Analysis of Gene Ontology (GO) biological processes identified GO terms that were significantly different among the Progressor, Non-progressor and healthy groups. For example, the GO term ‘detoxification of arsenic containing substances’ was significantly underrepresented in the Progressor group compared to healthy and Non-progressor groups. Furthermore, several bacterial enzymes were significantly different between the three groups. In particular, oxidoreductases were significantly decreased in the Progressor group compared to healthy and Non-progressor groups. While the implications of these significantly enriched or depleted bacterial biological processes and bacterial enzymes in the neoplastic progression of IBD warrant further investigation, the results from our current study provide new insight into understanding how gut microbiota as a modulator of microenvironment may contribute to progression of IBD-associated colorectal cancer. Citation Format: Nobel Bhasin, Prerna Dabral, Victoria Poplaski, Lisa Lai, Hong-Yuan Tsai, Mary Bronner, Teresa Brentnall, John Valentine, Jordon March, Antone Opekun, Robert Britton, Pan Sheng, Ru Chen. Metaproteomic analysis of IBD associated colorectal cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 5078.